News Corporate Actions Mardia Samyoung Converts 78.10 Lakh Warrants, Increases Capital to ₹14.76 CroreMardia Samyoung Converts 78.10 Lakh Warrants, Increases Capital to ₹14.76 Crore
Mardia Samyoung Capillary Tubes executed significant capital market transactions including allotment of 1,30,90,200 warrants to promoter entity Torextron Ventures and conversion of 78,10,000 warrants into equity shares for non-promoter investors, substantially increasing the company's paid-up share capital from ₹6.95 crore to ₹14.76 crore while maintaining regulatory compliance.
*this image is generated using AI for illustrative purposes only.
Mardia Samyoung Capillary Tubes Company Limited has completed significant corporate actions involving warrant allotments and conversions. The company recently allotted 1,30,90,200 fully convertible equity warrants to Torextron Ventures Private Limited on February 05, 2026, followed by the conversion of 78,10,000 warrants into equity shares on February 09, 2026.
Recent Warrant Allotment to Promoter Entity
The board of directors approved the allotment of 1,30,90,200 warrants to Torextron Ventures Private Limited during a meeting held on February 05, 2026. This transaction represents the second tranche of the company's preferential allotment program, executed at an issue price of ₹13.50 per warrant with a premium of ₹3.50 per warrant.
| Parameter: | Details |
|---|---|
| Total Warrants Allotted: | 1,30,90,200 |
| Issue Price: | ₹13.50 per warrant |
| Premium: | ₹3.50 per warrant |
| Allottee: | Torextron Ventures Private Limited |
| Category: | Promoter |
| Allotment Date: | February 05, 2026 |
Warrant Conversion and Equity Allotment
In a subsequent development, the company's board meeting on February 09, 2026, approved the allotment of 78,10,000 equity shares pursuant to the conversion of fully convertible equity warrants. These warrants were originally allotted on February 04, 2026, to non-promoter investors at the same issue price of ₹13.50 per warrant.
| Allottee Details: | Category | Equity Shares Allotted |
|---|---|---|
| Mistry Deep Dhirenbhai: | Non-Promoter | 39,00,000 |
| Sindhi Mohammad Mahin Salim: | Non-Promoter | 39,10,000 |
| Total: | - | 78,10,000 |
Capital Structure Impact
The warrant conversion has resulted in a substantial increase in the company's paid-up equity share capital. The capital structure has been enhanced from ₹6,94,80,730 divided into 69,48,073 equity shares to ₹14,75,80,730 divided into 1,47,58,073 equity shares, each with a face value of ₹10.
| Capital Details: | Before Conversion | After Conversion |
|---|---|---|
| Paid-up Capital: | ₹6,94,80,730 | ₹14,75,80,730 |
| Number of Shares: | 69,48,073 | 1,47,58,073 |
| Face Value: | ₹10 per share | ₹10 per share |
Regulatory Compliance and Framework
Both transactions were conducted in compliance with SEBI regulations. The warrant allotment to Torextron Ventures followed a special resolution passed during an Extraordinary General Meeting held on October 29, 2025, and received in-principle approval from the Bombay Stock Exchange on January 23, 2026. The company has adhered to SEBI (Issue of Capital and Disclosure Requirements) Regulations, 2018, and SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Corporate Governance and Timeline
The February 05, 2026 board meeting for warrant allotment was conducted from 3:00 PM to 3:30 PM, while the February 09, 2026 meeting for equity conversion was held from 5:30 PM to 6:00 PM. The company maintains transparency through proper regulatory disclosures and compliance with listing obligations, ensuring all stakeholders are informed of material developments affecting the capital structure.
15
